Oral terbinafine (lamisil◇) in the treatment of fungal infections of the skin and nails

Dermatology

Volumn 194, Issue 1, 1997, Pages 37-39

  Roberts, D T ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antifungal; Comparative trials; Dermatophyte; Itraconazole; Nail; Plantar; Safety profile; Scalp; Skin; Systemic; Topical

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ARTICLE; CANDIDIASIS; CELL WALL; DERMATOPHYTE; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; FOOT SOLE; GASTROINTESTINAL SYMPTOM; HAND PALM; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; SCALP; SKIN INFECTION; TINEA VERSICOLOR; TOPICAL DRUG ADMINISTRATION; TRICHOPHYTON; VAGINITIS;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DERMATOMYCOSES; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; ONYCHOMYCOSIS; TINEA CAPITIS; TREATMENT OUTCOME;

EID: 0030948257     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246183     Document Type: Article

References (13)

1. Ryder NS: The mechanism of action of ter-binaline. Clin Exp Dermatol 1989;14:98-100.
2. Clayton Y M: Relevance of broad spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130(suppl 43):7-10.
3. Faergemann J, Zchender H. Jones T. Mai-bach I: Terbinaline levels in serum, stratum corneum, dermis-epidermis, hair, sebum and eccrine sweat. Acta Derm Venereol (Stockh) 1991;71:322-326.
4. Haroon TS. et al: An open clinical pilot study of efficacy and safety of terbinafine in non-in-flammatory tinea capitis. BrJ Dermatol 1992; 126(suppl 39):47-50.
5. Farag A. Taha M. Halim S: One week therapy with oral terbinaline in cases of tinea corpo-ris/cruris. BrJ Dermatol 1994;131:684-687.
6. White JE. Evans EGV. Perkins P: Successful two-week treatment with terbinaline for moccasin tinea pedis and tinea manuum. Br J Dermatol 1992;125:260-262.
7. De Keyscr P. De Backer M. Masscrt DL. Wcsle-linck KJ: Two week treatment of tinea pedis, comparing terbinaline (250 mg daily) with itraconazole (100 mg daily): A double blind, multicentre study. Br J Dermatol 1994:130 (suppl 43):22-25.
8. Hay RJ. McGregor JM. Wutte J. Ryatt KS. Ziegler C, Clayton YM: A comparison of two weeks terbinafine 250 mg/day with four weeks of itraconazole 100 mg/day in plantar tinea pedis. BrJ Dermatol 1995:132:604-608.
9. Roberts DT: Prevalence of dermatophyte onychomycosis: Results of an omnibus survey. Br J Dermatol 1992:126(suppl 39):23-27.
10. Roberts DT: Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994;31: 578-581.
11. Arenas R. Dominguez-Cherit J. Fernandez LMA: Open randomized comparison of itraconazole vs terbinafine in onychomycosis. Ini J Dermatol 1995:34:138-143.
12. Brautigam M. Nolting S. Schopf RE. et al: Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br Med J 1995:311: 919-922.
13. Report of the UK post marketing surveillance study of oral l.amisil (terbinafine). BrJ Dermatol 1995; 13(suppl 45):27.